![evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States evaluate the pharmaceuticals company saxenda](https://photos.prnewswire.com/prnfull/20150421/200124LOGO)
evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States evaluate the pharmaceuticals company saxenda
USD26.10
USD50.10
Pay in 4 interest-free payments of $6.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
![evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States evaluate the pharmaceuticals company saxenda](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3760222644739223323)
![evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States evaluate the pharmaceuticals company saxenda](https://www.usnews.com/cmsmedia/ce/28/59c8177f437e85c2553c1df64f4f/gettyimages-2162809200.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States evaluate the pharmaceuticals company saxenda](https://innovative-care.com/wp-content/uploads/2024/05/iStock-2055844146.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States evaluate the pharmaceuticals company saxenda](https://images.everydayhealth.com/images/diet-nutrition/weight/prescription-weight-loss-medications-alt-1-1440x810.jpg?sfvrsn=5bb97b8b_3)
![evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States evaluate the pharmaceuticals company saxenda](https://www.singlecare.com/blog/wp-content/uploads/2025/09/FDA_approval_Saxenda.png)
![evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States evaluate the pharmaceuticals company saxenda](https://plexusdx.com/cdn/shop/articles/p3_df110284-0556-42e1-bd82-0d892219e1c1.jpg?v=1780427712&width=4608)
